Good News--MS Drugs Taken While Breastfeeding May Not Affect Child Development
Retrieved on:
星期二, 三月 5, 2024
NMOSD, Social media, Hellwig, Nervous system, Alzheimer's disease, MD, Ofatumumab, Stroke, German, Pregnancy, Life, Risk, Annual general meeting, Multiple sclerosis, DSM-IV codes, AAN, Health, Migraine, Parkinson's disease, Hypoesthesia, Fatigue, Ruhr University Bochum, Mother, Paresthesia, Infant, Concussion, Spinal cord, Breast milk, Epilepsy, Sclerosis, Disease, Child, Rituximab, Natalizumab, Optic nerve, Brain, Demyelinating disease, Research, Immune system, American Academy, Birth control
MS is a disease in which the body's immune system attacks myelin, the fatty white substance that insulates and protects the nerves.
Key Points:
- MS is a disease in which the body's immune system attacks myelin, the fatty white substance that insulates and protects the nerves.
- For the study, researchers used the German MS and Pregnancy Registry to identify 183 infants born to mothers taking monoclonal antibodies while breastfeeding.
- The first exposures to the medications through breastfeeding ranged from the day a child was born to the ninth month of life.
- After comparing infants exposed to the medications to infants not exposed, researchers found no differences in their health or development.